Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27329 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Nicholas J Short und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Pyridazines, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Imidazoles, Philadelphia Chromosome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH/NCI Cancer Center Support Grant P30.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Nicholas J Short, Elias Jabbour, Lewis F Nasr, Nitin Jain, Fadi G Haddad, Ghayas C Issa, Koji Sasaki, Jayastu Senapati, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
Förderung
- NCI NIH HHS
- NIH/NCI Cancer Center Support Grant P30
Zitieren
APA
Short, N. J., Jabbour, E., Nasr, L. F., Jain, N., Haddad, F. G., Issa, G. C., Sasaki, K., Senapati, J., Kebriaei, P., Garris, R., Konopleva, M., Ravandi, F., & Kantarjian, H. (2024). Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy. American Journal of Hematology. https://doi.org/10.1002/ajh.27329
Vancouver
Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, et al. Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy. American Journal of Hematology. 2024. doi:10.1002/ajh.27329
BibTeX
@article{Short2024,
author = {Short, Nicholas J and Jabbour, Elias and Nasr, Lewis F and Jain, Nitin and Haddad, Fadi G and Issa, Ghayas C and Sasaki, Koji and Senapati, Jayastu and Kebriaei, Partow and Garris, Rebecca and Konopleva, Marina and Ravandi, Farhad and Kantarjian, Hagop},
title = {Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27329}
}
EUVIMED